PubMed · 2010 · 62 citations · 13 references
MedicineOncologyPharmacologyCancer GeneticsMolecular OncologyNeoplasiaLung CancerMalignant NeoplasmsOncogene MutationsOncogenic Signaling PathwaysTyrosine Kinase InhibitorsEgfr InhibitionEpidermal Growth Factor Receptor InhibitionKinase Inhibitor ResistanceNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentOncogenic Receptor Tyrosine Kinase MutationsTherapeutic Tyrosine Kinase InhibitorsTyrosine Kinase Inhibitor Therapy
BACKGROUND: Concurrent presence of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC) patients is relatively rare and their appearance is believed to be mutually exclusive. Tumours harbouring KRAS mutation are perceived as not being capable of response to tyrosine kinase inhibitor (TKI) therapy. PATIENTS AND METHODS: This paper presents 5 case reports of patients with tumours harbouring multiple EGFR and/or KRAS mutations. There were 3 patients with EGFR mutations (2 x exon 19 deletions, 1 x L858R) combined with KRAS mutations (2 x Gly12Asp, 1 x Gly12Val), 1 patient with two EGFR mutations (exon 19 deletion + L858R) and 1 patient with two KRAS mutations (Ala11Pro + Gly12Val). RESULTS: All EGFR(+)/KRAS(+) patients had initially showed positive response to TKI treatment. The EGFR(+)/EGFR(+) patient has exhibited strong rash and good response with the best survival, while the KRAS(+)/KRAS(+) patient did not respond to TKI therapy. CONCLUSION: EGFR(+)/KRAS(+) combination does not necessarily pose a negative prediction. This is probably due to the multiclonal character of the tumour displaying partial response in the EGFR(+) subpopulation.
13
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee et al. · Science · 2004 · 9.4K citations
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
Rafael Rosell, Teresa Morán, Cristina Queralt et al. · New England Journal of Medicine · 2009 · 2.4K citations · Full text
Gregory J. Riely, William Pao, DuyKhanh Pham et al. · Clinical Cancer Research · 2006 · 742 citations
Chang‐Qi Zhu, Gilda da Cunha Santos, Keyue Ding et al. · Journal of Clinical Oncology · 2008 · 665 citations · Full text